Clinical trialNCT06613698RecruitingPhase 2Interventional

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

SponsorGlaxoSmithKlineEnrollment393Liver Diseases, Alcoholic

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

140 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Gsk Investigational Site
Buenos Aires, Argentina
Fernando Gruz
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Marcela Paola Alicia De Sousa Coelho
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Maria Anders
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Juan Bandi
Recruiting
Gsk Investigational Site
Ciudad AutOnoma de Buenos Aire, Argentina
Nora Cejas
Recruiting
Gsk Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina
Matias Bori
Recruiting
Gsk Investigational Site
Rosario, Argentina
Juan Favareto
Recruiting
Gsk Investigational Site
Rosario, Argentina
Fernando Bessone
Recruiting
Gsk Investigational Site
San Miguel de Tucumán, Argentina
Ana Palazzo
Recruiting

Australia

Gsk Investigational Site
Adelaide, South Australia, Australia
Edmund Tse
Recruiting
Gsk Investigational Site
Melbourne, Victoria, Australia
William Kemp
Recruiting
Gsk Investigational Site
Parkville Melbourne, Victoria, Australia
Ashok Raj
Recruiting
Gsk Investigational Site
Murdoch, Western Australia, Australia
Oyekoya Ayonrinde
Recruiting
Gsk Investigational Site
Perth, Western Australia, Australia
Tim Mitchell
Recruiting

Canada

Gsk Investigational Site
Calgary, Alberta, Canada
Henry Nguyen
Recruiting
Gsk Investigational Site
New Westminster, British Columbia, Canada
Steven Cheuk-Fung Pi
Recruiting
Gsk Investigational Site
Vancouver, British Columbia, Canada
Alnoor Ramji
Recruiting
Gsk Investigational Site
London, Ontario, Canada
Mohammad Qasim Khan
Recruiting
Gsk Investigational Site
Toronto, Ontario, Canada
Jordan Feld
Recruiting
Gsk Investigational Site
Toronto, Ontario, Canada
Gerald Chan
Recruiting
Gsk Investigational Site
Montreal, Quebec, Canada
Julian Hercun
Recruiting
Gsk Investigational Site
Terrebonne, Quebec, Canada
Yves Robitaille
Recruiting

Denmark

Gsk Investigational Site
Esbjerg, Denmark
Mette Munk Lauridsen
Recruiting
Gsk Investigational Site
Hvidovre, Denmark
Lise Lotte Gluud
Recruiting
Gsk Investigational Site
Odense C, Denmark
Camilla Hansen
Recruiting

France

Gsk Investigational Site
Angers, France
Jerome Boursier
Recruiting
Gsk Investigational Site
Bobigny, France
Nathalie Ganne-Carrie
Recruiting
Gsk Investigational Site
Créteil, France
Jean-Philippe Richardet
Recruiting
Gsk Investigational Site
Lille, France
PHILIPPE MATHURIN
Recruiting
Gsk Investigational Site
Montpellier, France
José URSIC BEDOYA
Recruiting
Gsk Investigational Site
Rouen, France
Ghassan Riachi
Recruiting

Germany

Gsk Investigational Site
Bochum, North Rhine-Westphalia, Germany
Isabell Hanitz
Recruiting
Gsk Investigational Site
Berlin, Germany
Keikawus Arasteh
Recruiting
Gsk Investigational Site
Berlin, Germany
Muenevver Demir
Recruiting
Gsk Investigational Site
Kiel, Germany
Rainer Guenther
Recruiting
Gsk Investigational Site
Leipzig, Germany
Ingolf Schiefke
Recruiting
Gsk Investigational Site
Mainz, Germany
Christian Labenz
Recruiting

Greece

Gsk Investigational Site
Athens, Greece
Evangelos Cholongitas
Recruiting
Gsk Investigational Site
Athens, Greece
Vasileios Sevastianos
Recruiting
Gsk Investigational Site
Athens, Greece
George Papatheodoridis
Recruiting

100 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GSK4532990Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Sept 2024
Primary completion: 26 Nov 2027
Completion: 7 Mar 2028
Last update posted: 3 Aug 2026
Registered enrollment: 393
Registry id: NCT06613698

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-511596-15

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.